股本结构
单位：万股
| 公告日期 | 2026-08-06 | 2026-08-06 | 2026-05-07 | 2026-05-07 | 2026-03-05 | 2026-03-05 |
|---|---|---|---|---|---|---|
| 证券总股本 | 457.74 | 406.90 | 361.21 | 360.76 | 356.04 | 350.56 |
| 普通股本 | 457.74 | 406.90 | 361.21 | 360.76 | 356.04 | 350.56 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2026-07-31 | 2026-06-30 | 2026-05-01 | 2026-03-31 | 2026-02-27 | 2025-12-31 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2026-08-06 | 457.74 | 未披露 | 定期报告 | 2026-07-31 |
| 2026-08-06 | 406.90 | 未披露 |
更多>>
From March 31,2026 to June 30,2026
Exercise of pre-funded warrants
Issuance of shares under ESPP
|
2026-06-30 |
| 2026-05-07 | 361.21 | 未披露 | 定期报告 | 2026-05-01 |
| 2026-05-07 | 360.76 | 未披露 |
更多>>
From December 31,2025 to March 31,2026
Exercise of stock options
Issuance of shares from at-the-market sales, net of expenses
|
2026-03-31 |
| 2026-03-05 | 356.04 | 未披露 | 定期报告 | 2026-02-27 |
| 2026-03-05 | 350.56 | 未披露 |
更多>>
From December 31, 2024 to December 31, 2025
Issuance of shares under ESPP
Issuances of Common Stock and accompanying pre-funded warrants at Private Placement, net of issuance costs of $1,223
Exercise of pre-funded warrants
Reverse Split (1 for 12) adjustment
|
2025-12-31 |
| 2025-12-19 | 350.56 | 未披露 | 定期报告 | 2025-12-17 |
| 2025-11-26 | 520.33 | 未披露 | 定期报告 | 2025-11-25 |
| 2025-11-17 | 338.83 | 未披露 |
更多>>
Common Stock offered 708,428 shares by the company
|
2025-11-14 |
| 2025-12-19 | 267.98 | 未披露 | 定期报告 | 2025-10-31 |
| 2025-11-05 | 267.61 | 未披露 |
更多>>
From June 30, 2025 to September 30, 2025
Reclass of mezzanine equity
Reverse Split (1 for 12) adjustment
|
2025-09-30 |
| 2025-08-07 | 267.61 | 未披露 | 定期报告 | 2025-08-04 |
| 2025-07-18 | 267.62 | 未披露 | 定期报告 | 2025-07-17 |
| 2025-07-10 | 233.75 | 未披露 |
更多>>
a one-for-twelve reverse stock split of its common stock
|
2025-07-14 |
| 2025-04-25 | 2805.02 | 未披露 | 定期报告 | 2025-04-23 |
| 2025-03-06 | 2800.67 | 未披露 |
更多>>
From December 31, 2023 to December 31, 2024
Issuance of shares under ESPP
Exercise of stock options
Issuance of shares from at-the-market sales, net of expenses
|
2024-12-31 |
| 2024-11-07 | 2800.67 | 未披露 | 定期报告 | 2024-11-01 |
| 2024-08-01 | 2797.58 | 未披露 |
更多>>
From March 31, 2024 to June 30, 2024
Exercise of stock options
Issuance of shares from at-the-market sales, net of expenses
Issuance of shares under ESPP
|
2024-06-30 |
| 2024-04-26 | 2797.33 | 未披露 | 定期报告 | 2024-04-24 |
| 2024-05-02 | 2790.36 | 未披露 |
更多>>
From December 31, 2023 to March 31, 2024
Exercise of stock options
|
2024-03-31 |
| 2024-03-21 | 2790.30 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Exercise of stock options
Issuance of shares under ESPP
|
2023-12-31 |
| 2023-11-02 | 2790.30 | 未披露 | 定期报告 | 2023-10-30 |
| 2023-08-03 | 2784.00 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Exercise of stock options
Issuance of shares under ESPP
|
2023-06-30 |
| 2023-05-04 | 2783.49 | 未披露 | 定期报告 | 2023-05-01 |
| 2023-04-28 | 2782.20 | 未披露 | 定期报告 | 2023-04-24 |
| 2023-03-02 | 2777.45 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Exercise of stock options
Issuance of shares under ESPP
|
2022-12-31 |
| 2022-11-03 | 2777.45 | 未披露 | 定期报告 | 2022-11-01 |
| 2022-08-04 | 2774.88 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Exercise of stock options
Issuance of shares under ESPP
|
2022-06-30 |
| 2022-05-05 | 2774.72 | 未披露 | 定期报告 | 2022-05-04 |
| 2022-04-29 | 2774.33 | 未披露 | 定期报告 | 2022-04-25 |
| 2022-05-05 | 2772.52 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Exercise of stock options
|
2022-03-31 |
| 2022-03-03 | 2772.43 | 未披露 | 定期报告 | 2022-03-02 |
| 2022-03-03 | 2768.10 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Exercise of stock options
|
2021-12-31 |
| 2021-11-04 | 2762.62 | 未披露 | 定期报告 | 2021-11-03 |
| 2021-11-04 | 2761.98 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Exercise of stock options
|
2021-09-30 |
| 2021-08-05 | 2761.16 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Exercise of stock options
|
2021-06-30 |
| 2021-04-29 | 2760.99 | 未披露 | 定期报告 | 2021-04-26 |
| 2021-05-06 | 2760.44 | 未披露 |
更多>>
From December 31, 2020 to March 31, 2021
Issuance of common stock
|
2021-03-31 |
| 2021-03-04 | 2759.99 | 未披露 | 定期报告 | 2021-03-03 |
| 2021-03-04 | 2756.88 | 未披露 |
更多>>
From December 31,2019 to December 31,2020
Issuance of common stock
|
2020-12-31 |
| 2020-11-05 | 2755.31 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Issuance of common stock
|
2020-09-30 |
| 2020-08-06 | 2755.28 | 未披露 | 定期报告 | 2020-08-05 |
| 2020-08-06 | 2752.07 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Issuance of common stock
|
2020-06-30 |
| 2020-05-07 | 2751.74 | 未披露 | 定期报告 | 2020-05-06 |
| 2020-04-27 | 2751.69 | 未披露 | 定期报告 | 2020-04-16 |
| 2020-05-07 | 2751.64 | 未披露 |
更多>>
From December 31, 2019 to March 31, 2020
Issuance of common stock
|
2020-03-31 |
| 2020-03-12 | 2750.95 | 未披露 | 定期报告 | 2020-03-11 |
| 2020-03-12 | 2749.93 | 未披露 |
更多>>
From December 31, 2018 To December 31, 2019
Conversion of preferred stock to common stock
Public offerings of common stock, net of issuance costs of $20.7M
Issuance of common stock
|
2019-12-31 |
| 2019-11-19 | 2681.65 | 未披露 |
更多>>
NextCure, Inc. is offering 4,077,192 shares of common stock.
|
2019-11-19 |
| 2019-11-12 | 2275.40 | 未披露 | 定期报告 | 2019-11-08 |
| 2019-11-12 | 2273.93 | 未披露 |
更多>>
from June 30, 2019 to September 30, 2019
Issuance of common stock
|
2019-09-30 |
| 2019-08-12 | 2271.48 | 未披露 |
更多>>
from March 31, 2019 to June 30,2019
Conversion of preferred stock to common stock
Initial public offering, net of issuance costs of $9.4M
Issuance of common stock upon exercise of vested options, $.001 par value
|
2019-06-30 |
| 2019-06-10 | 2271.48 | 未披露 | 定期报告 | 2019-06-07 |
| 2019-05-09 | 2193.54 | 未披露 |
更多>>
1.Common stock offered 5,000,000 shares
2.The number of shares of common stock to be outstanding after this offering is based on 16,935,381 shares of common stock outstanding as of December 31, 2018, which includes 272,802 shares of restricted common stock that were unvested or subject to repurchase at December 31, 2018
3.a 1-for-8.0338 reverse stock split effected on May 3, 2019
|
2019-05-09 |
| 2019-06-10 | 137.95 | 12501.07 |
更多>>
From December 31, 2018 To March 31, 2019
Issuance of common stock
|
2019-03-31 |
| 2019-04-12 | 1104.50 | 12501.07 | 定期报告 | 2018-12-31 |
From March 31,2026 to June 30,2026
Exercise of pre-funded warrants
Issuance of shares under ESPP
From December 31,2025 to March 31,2026
Exercise of stock options
Issuance of shares from at-the-market sales, net of expenses
From December 31, 2024 to December 31, 2025
Issuance of shares under ESPP
Issuances of Common Stock and accompanying pre-funded warrants at Private Placement, net of issuance costs of $1,223
Exercise of pre-funded warrants
Reverse Split (1 for 12) adjustment
Common Stock offered 708,428 shares by the company
From June 30, 2025 to September 30, 2025
Reclass of mezzanine equity
Reverse Split (1 for 12) adjustment
a one-for-twelve reverse stock split of its common stock
From December 31, 2023 to December 31, 2024
Issuance of shares under ESPP
Exercise of stock options
Issuance of shares from at-the-market sales, net of expenses
From March 31, 2024 to June 30, 2024
Exercise of stock options
Issuance of shares from at-the-market sales, net of expenses
Issuance of shares under ESPP
From December 31, 2023 to March 31, 2024
Exercise of stock options
From December 31, 2022 to December 31, 2023
Exercise of stock options
Issuance of shares under ESPP
From March 31, 2023 to June 30, 2023
Exercise of stock options
Issuance of shares under ESPP
From December 31, 2021 to December 31, 2022
Exercise of stock options
Issuance of shares under ESPP
From March 31, 2022 to June 30, 2022
Exercise of stock options
Issuance of shares under ESPP
From December 31, 2021 to March 31, 2022
Exercise of stock options
From December 31, 2020 to December 31, 2021
Exercise of stock options
From June 30, 2021 to September 30, 2021
Exercise of stock options
From March 31, 2021 to June 30, 2021
Exercise of stock options
From December 31, 2020 to March 31, 2021
Issuance of common stock
From December 31,2019 to December 31,2020
Issuance of common stock
From June 30, 2020 to September 30, 2020
Issuance of common stock
From March 31, 2020 to June 30, 2020
Issuance of common stock
From December 31, 2019 to March 31, 2020
Issuance of common stock
From December 31, 2018 To December 31, 2019
Conversion of preferred stock to common stock
Public offerings of common stock, net of issuance costs of $20.7M
Issuance of common stock
NextCure, Inc. is offering 4,077,192 shares of common stock.
from June 30, 2019 to September 30, 2019
Issuance of common stock
from March 31, 2019 to June 30,2019
Conversion of preferred stock to common stock
Initial public offering, net of issuance costs of $9.4M
Issuance of common stock upon exercise of vested options, $.001 par value
1.Common stock offered 5,000,000 shares
2.The number of shares of common stock to be outstanding after this offering is based on 16,935,381 shares of common stock outstanding as of December 31, 2018, which includes 272,802 shares of restricted common stock that were unvested or subject to repurchase at December 31, 2018
3.a 1-for-8.0338 reverse stock split effected on May 3, 2019
From December 31, 2018 To March 31, 2019
Issuance of common stock